Search Results

By Cesar A. Santa-Maria, MD, MSCI, Ashley Cimino-Mathews, MD, and Antonio C. Wolff, MD, FACP, FASCO  / November 25, 2017

Gene-Expression Assays in Early-Stage Breast Cancer: Who Should Order Them and When?

A deeper understanding of biology has allowed significant advances in the treatment of breast cancer. In the early-stage setting, standard pathology measures can help identify which subset of patients with hormone receptor–positive breast cancers are more likely to experience benefit from...